Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001437749-25-037164
Filing Date
2025-12-08
Accepted
2025-12-08 16:47:01
Documents
1
Period of Report
2025-12-02

Document Format Files

Seq Description Document Type Size
1 FORM 4 rdgdoc.html 4  
1 FORM 4 rdgdoc.xml 4 5611
  Complete submission text file 0001437749-25-037164.txt   6988
Mailing Address 1000 SKOKIE BLVD SUITE 350 WILMETTE IL 60091
Business Address 1000 SKOKIE BLVD SUITE 350 WILMETTE IL 60091 8473880349
Monopar Therapeutics (Issuer) CIK: 0001645469 (see all company filings)

EIN.: 320463781 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 22616 ERWIN STREET WOODLAND HILLS CA 91367
Business Address
Vu Quan Anh (Reporting) CIK: 0001892297 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39070 | Film No.: 251556678